IRIS
SAMBATARO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.852
AS - Asia 911
EU - Europa 373
SA - Sud America 220
AF - Africa 17
OC - Oceania 1
Totale 3.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.816
SG - Singapore 336
HK - Hong Kong 192
CN - Cina 170
BR - Brasile 163
IT - Italia 144
VN - Vietnam 111
DE - Germania 61
FR - Francia 53
AR - Argentina 26
IE - Irlanda 24
BD - Bangladesh 21
CA - Canada 21
GB - Regno Unito 20
IN - India 18
AT - Austria 17
ID - Indonesia 15
NL - Olanda 13
EC - Ecuador 12
FI - Finlandia 10
MX - Messico 10
TR - Turchia 9
IQ - Iraq 8
CO - Colombia 6
PL - Polonia 6
RU - Federazione Russa 6
ZA - Sudafrica 6
CL - Cile 5
ES - Italia 5
MA - Marocco 5
AZ - Azerbaigian 4
JP - Giappone 4
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
IL - Israele 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
UA - Ucraina 2
VE - Venezuela 2
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.374
Salva come PNG Salva come JPEG
Città #
Dallas 1.205
Hong Kong 191
San Jose 156
Singapore 149
Ashburn 101
Ho Chi Minh City 54
The Dalles 44
Chicago 41
Beijing 36
Dublin 24
Milan 23
Santa Clara 17
São Paulo 16
Naples 15
New York 15
Hanoi 13
Catania 12
Hillsboro 11
Frankfurt am Main 10
Montreal 9
Helsinki 8
Orem 8
Rio de Janeiro 8
Amsterdam 7
Boardman 7
Istanbul 7
Munich 7
Palermo 7
Chennai 6
Council Bluffs 6
Düsseldorf 6
Los Angeles 6
Mexico City 6
Quito 6
Biên Hòa 5
Brasília 5
Manchester 5
Misilmeri 5
Nuremberg 5
Porto Alegre 5
Vienna 5
Warsaw 5
Assago 4
Baghdad 4
Baku 4
Boston 4
Brooklyn 4
Curitiba 4
Dhaka 4
Guayaquil 4
Haiphong 4
Limburg an der Lahn 4
Rome 4
Triggiano 4
Turin 4
Bologna 3
Campinas 3
Casoria 3
Durban 3
Ealing 3
Guarulhos 3
Joinville 3
Resistencia 3
Ribeirão Preto 3
San Francisco 3
Seattle 3
Tashkent 3
Varallo Pombia 3
Abbotsford 2
Alessandria 2
Avellino 2
Bandung 2
Belo Horizonte 2
Bogotá 2
Buenos Aires 2
Buritama 2
Can Tho 2
Chittagong 2
Corato 2
Cypress 2
Da Nang 2
Duque de Caxias 2
Fortaleza 2
General Roca 2
Hortolândia 2
Hải Dương 2
Ijuí 2
Independencia 2
Isidro Casanova 2
Johannesburg 2
Kyiv 2
Lauterbourg 2
Lima 2
London 2
Machala 2
Manaus 2
Miami 2
Moscow 2
Mumbai 2
Osaka 2
Totale 2.432
Salva come PNG Salva come JPEG
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 280
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 255
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 231
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 187
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 86
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 81
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 74
Brain Metastasis in Endometrial Cancer: A Systematic Review 73
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 68
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 64
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 62
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 58
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 57
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 57
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 57
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 55
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 54
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 54
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 54
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 53
Chemotherapy extravasation: diagnosis, prevention and management 52
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 52
[Second-line chemotherapy and new drugs for ovarian carcinoma] 51
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 50
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 50
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 49
Prognostic Factors for Adrenocortical Carcinoma Outcomes 49
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 47
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 46
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 45
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 43
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 41
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 41
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 39
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 39
Bronchial carcinoid associated with Cushing's syndrome 39
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 36
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 33
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 31
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 29
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 29
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 25
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 23
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 22
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 21
Follow up of colorectal cancer 19
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 19
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 19
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 18
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 18
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 17
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 17
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 17
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 17
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 16
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 16
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 15
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 15
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 14
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 14
Nutritional Status, Inflammatory Parameters and Cancer 14
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 14
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 14
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 14
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 14
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 13
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 13
Trombosi e Cancro 13
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 13
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 13
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 13
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 12
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 12
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 12
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 12
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 11
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 11
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 10
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 10
Tromboembolismo in oncologia medica 10
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 10
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 10
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 10
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 10
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 10
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 9
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 9
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 9
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 8
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 8
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 6
Totale 3.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20262.937 103 282 1.122 256 230 221 124 253 195 151 0 0
Totale 3.552